Kyverna Therapeutics, Inc. Common Stock (KYTX)

Typically moves ±7.01% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-12 ESTIMATED
search

Kyverna Therapeutics, Inc. Common Stock (KYTX) has reported earnings 11 times since Mar 26, 2024. The stock moves an average of ±7.01% the day after reporting, closing higher 45.5% of the time. Its largest post-earnings gain was +15.67% (Aug 12, 2025) and its largest decline was -15.25% (Mar 27, 2025). The next earnings report is predicted for 2026-11-12 (estimated).

Earnings reactions

How KYTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

11

Avg Abs. Movement

±7.01%

Positive %

45.5%

Negative %

54.5%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 11, 2026 ☽ POST +0.75% open_in_new
May 12, 2026 ☽ POST +5.28% open_in_new
Mar 26, 2026 ☽ POST -2.5% open_in_new
Nov 12, 2025 ☽ POST -11.6% open_in_new
event

Earnings Count

11

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.01%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →
18
Funds holding
$101364825
Total value held
Buying
15 added · 1 reduced
Gilead Sciences, Inc.
$36763720 Held
Blackrock, Inc.
$27931130 +257.41%
Morgan Stanley
$8752355 +0.51%
State Street Corp
$8751696 +610.22%
Wells Fargo & Company/Mn
$3323510 +226.06%

Frequently asked about KYTX earnings

When does Kyverna Therapeutics, Inc. Common Stock report earnings next? expand_more

Kyverna Therapeutics, Inc. Common Stock (KYTX)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KYTX stock move after earnings? expand_more

Over 11 reports, KYTX has moved an average of ±7.01% the session after earnings, closing higher 45.5% of the time.

What was KYTX's biggest post-earnings move? expand_more

KYTX's largest post-earnings gain on record was +15.67% on Aug 12, 2025, and its largest decline was -15.25% on Mar 27, 2025.

Where can I find Kyverna Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Kyverna Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.